Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 2009 Nov;158(Suppl 1):S184–S186. doi: 10.1111/j.1476-5381.2009.00505_2.x

ATP-binding cassette family

PMCID: PMC2884629

Overview: ATP-binding cassette transporters are ubiquitous membrane proteins characterized by facilitated movement of a range of substrates, including ions, lipids, peptides, steroids. The functional transporter is probably dimeric, with individual subunits typically made up of two groups of 6TM-spanning domains, with two nucleotide-binding domains (NBD). The majority of eukaryotic ATP-binding cassette (ABC) transporters are ‘full’ transporters incorporating both TM and NBD entities. Some ABCs, notably the ABCD family, appear relatively truncated and are only functional as homo- or heterodimers. Eukaryotic ABC transporters convey substrates from the cytoplasm, either out of the cell or into intracellular organelles. Their role in the efflux of exogenous compounds, notably chemotherapeutic agents, has led to considerable interest.

Systematic name Common abbreviation Other names Ensembl ID Comments
ABCA1 ABC1, CERP Cholesterol efflux regulatory protein ENSG00000165029 Loss-of-function mutations are associated with Tangier disease, in which plasma HDL cholesterol levels are greatly reduced
ABCA2 ABC2 ENSG00000107331
ABCA3 ABC3, ABCC ENSG00000167972 Loss-of-function mutations are associated with pulmonary surfactant deficiency
ABCA4 ABCR Retinal-specific ATP-binding cassette transporter, RIM ABC transporter, RmP, Stargardt disease protein ENSG00000198691 Retinal-specific transporter of N-retinylPE; loss-of-function mutations are associated with Stargardt disease, a juvenile onset macular degenerative disease
ABCA5 ENSG00000154265
ABCA6 ENSG00000154262
ABCA7 ENSG00000064687
ABCA8 KIAA0822 ENSG00000141338
ABCA9 ENSG00000154258
ABCA10 ENSG00000154263
ABCA12 ENSG00000144452 Reported to play a role in skin ceramide formation (Zuo et al., 2008)
ABCA13 ENSG00000179869
ABCA14 ENSMUSG00000062017 No orthologue in man
ABCA15 ENSMUSG00000054746 No orthologue in man
ABCA16 ENSMUSG00000051900 No orthologue in man
ABCA17 ENSMUSG00000035435 No orthologue in man
ABCB1 MDR1, PGP1 Multi-drug resistance protein 1, P-glycoprotein 1, CD243 antigen ENSG00000085563 Responsible for the cellular export of many therapeutic drugs
ABCB2 TAP1 Antigen peptide transporter 1, APT1, peptide transporter TAP1, peptide supply factor 1 (PSF-1), peptide transporter involved in antigen processing 1 ENSG00000168394 Endoplasmic reticulum, possibly as heterodimer with TAP2
ABCB3 TAP2 Antigen peptide transporter 2 (APT2), Peptide transporter TAP2, peptide supply factor 2 (PSF-2), peptide transporter involved in antigen processing 2 ENSG00000204267 Endoplasmic reticulum, possibly as heterodimer with TAP1
ABCB4 PGY3 Multi-drug resistance protein 3, P-glycoprotein 3 ENSG00000005471 Transports PC from intracellular to extracellular face of the hepatocyte canalicular membrane (Oude Elferink and Paulusma, 2007)
ABCB5 P-glycoprotein ABCB5 ENSG00000004846
ABCB6 MTABC3 Mitochondrial ABC transporter 3, ubiquitously expressed mammalian ABC half transporter, P-glycoprotein-related protein ENSG00000115657 Mitochondrial
ABCB7 ABC7 ENSG00000131269 Mitochondrial; reportedly essential for haematopoiesis (Pondarre et al., 2007)
ABCB8 MABC1 ENSG00000197150 Mitochondrial; suggested to play a role in chemoresistance of melanoma (Elliott and Al-Hajj, 2009)
ABCB9 TAPL TAP-like protein, hABCB9 ENSG00000150967 Reported to be lysosomal (Kamakura et al., 2008)
ABCB10 MTABC2 Mitochondrial ABC transporter 2 ENSG00000135776 Mitochondrial
ABCB11 ABC16 Bile salt export pump, BSEP, PFIC-2, PFIC2, PGY4, SPGP ENSG00000073734 Loss-of-function mutations are associated with familial intrahepatic cholestasis (Stieger, 2009)
ABCC1 MRP1 Multidrug resistance-associated protein 1, Leukotriene C4 transporter ENSG00000103222 Exhibits a broad substrate specificity (Bakos and Homolya, 2007)
ABCC2 MRP2, cMOAT Multidrug resistance-associated protein 2, Canalicular multispecific organic anion transporter 1, Canalicular multidrug resistance protein ENSG00000023839 Loss-of-function mutations are associated with Dubin-Johnson syndrome, in which plasma levels of conjugated bilirubin are elevated
ABCC3 MRP3 Multidrug resistance-associated protein 3, Canalicular multispecific organic anion transporter 2, Multi-specific organic anion transporter-D, MOAT-D ENSG00000108846 Transports conjugates of glutathione, sulphate or glucuronide (see Borst et al., 2007)
ABCC4 MRP4 Multidrug resistance-associated protein 4, Multi-specific organic anion transporter-B, MOAT-B ENSG00000125257 Although reported to facilitate cellular cyclic nucleotide export, this role has been questioned (see Borst et al., 2007); reported to export prostaglandins in a manner sensitive to NSAIDS (Reid et al., 2003)
ABCC5 MRP5 Multidrug resistance-associated protein 5, Multi-specific organic anion transporter-C, MOAT-C, pABC11, SMRP ENSG00000114770 Although reported to facilitate cellular cyclic nucleotide export, this role has been questioned (see Borst et al., 2007)
ABCC6 MRP6 Multidrug resistance-associated protein 6, Anthracycline resistance-associated protein, Multi-specific organic anion transporter-E, MOAT-E ENSG00000091262
ABCC7 CFTR Cystic fibrosis transmembrane conductance regulator, cAMP-dependent chloride channel ENSG00000001626 See page S131
ABCC8 SUR1 Sulfonylurea receptor 1 ENSG00000006071 See page S141
ABCC9 SUR2 Sulfonylurea receptor 2 ENSG00000069431 See page S141
ABCC10 MRP7 Multidrug resistance-associated protein 7 ENSG00000124574
ABCC11 MRP8 Multidrug resistance-associated protein 8 ENSG00000121270 Single nucleotide polymorphisms distinguish wet vs. dry earwax; reported to export chemotherapeutic nucleotides (Oguri et al., 2007)
ABCC12 MRP9 Multidrug resistance-associated protein 9 ENSG00000140798
ABCC13 Putative ATP-binding cassette transporter C13 ENSG00000155288 A possible pseudogene
ABCD1 ALDP Adrenoleukodystrophy protein ENSG00000101986 Peroxisomal
ABCD2 ALDR Adrenoleukodystrophy- related protein, adrenoleukodystrophy-like 1 ENSG00000173208 Peroxisomal
ABCD3 PMP70 70 kDa peroxisomal membrane protein, PXMP1 ENSG00000117528 Peroxisomal
ABCD4 PMP69 Peroxisomal membrane protein 69, peroxisomal membrane protein 1-like, PXMP1-L, P70R ENSG00000119688 Peroxisomal
ABCE1 OABP RNase L inhibitor, ribonuclease 4 inhibitor, RNS4I, 2′-5′ oligoadenylate-binding protein ENSG00000164163 Lacks transport function
ABCF1 ABC50 TNF-α-stimulated ABC protein ENSG00000204574 Lacks transport function
ABCF2 Iron-inhibited ABC transporter 2 ENSG00000033050 Lacks transport function
ABCF3 ENSG00000161204 Lacks transport function
ABCG1 ABC8 White protein homolog ENSG00000160179
ABCG2 ABCP Placenta-specific ATP-binding cassette transporter, breast cancer resistance protein, BCRP, mitoxantrone resistance-associated protein, MXR, CD338 antigen, CDw338 ENSG00000118777
ABCG4 White2 ENSG00000172350
ABCG5 White3, Sterolin-1 ENSG00000138075
ABCG8 Sterolin-2 ENSG00000143921

ABCC8 and ABCC9 are unusual in that they lack transport capacity but regulate the activity of particular K+ channels (Kir6.1-6.2), conferring nucleotide sensitivity to these channels to generate the canonical KATP channels.

Glossary

Abbreviations:

ABC

ATP-binding cassette

NBD

nucleotide-binding domain

N-retinylPE

N-retinylphosphatidylethanolamine

NSAID

non-steroidal anti-inflammatory drugs

PC

phosphatidylcholine

Further Reading

Aye IL, Singh AT, Keelan JA (2009). Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability and function. Chem Biol Interact180: 327–339.

Borst P, de Wolf C, van de Wetering K (2007). Multidrug resistance–associated proteins 3, 4, and 5. Pflugers Arch453: 661–673.

Bryan J, Munoz A, Zhang X, Dufer M, Drews G, Krippeit–Drews P et al. (2007). ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Arch453: 703–718.

Ecker GF, Stockner T, Chiba P (2008). Computational models for prediction of interactions with ABC–transporters. Drug Discov Today13: 311–317.

Linton KJ, Higgins CF (2007). Structure and function of ABC transporters: the ATP switch provides flexible control. Pflugers Arch453: 555–567.

Procko E, O'Mara ML, Bennett WF, Tieleman DP, Gaudet R (2009). The mechanism of ABC transporters: general lessons from structural and functional studies of an antigenic peptide transporter. FASEB J23: 1287–1302.

Ravna AW, Sager G (2009). Molecular modeling studies of ABC transporters involved in multidrug resistance. Mini Rev Med Chem9: 186–193.

Rees DC, Johnson E, Lewinson O (2009). ABC transporters: the power to change. Nat Rev Mol Cell Biol10: 218–227.

Russel FG, Koenderink JB, Masereeuw R (2008). Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci29: 200–207.

Schrickx JA, Fink-Gremmels J (2008). Implications of ABC transporters on the disposition of typical veterinary medicinal products. Eur J Pharmacol585: 510–519.

Seeger MA, van Veen HW (2009). Molecular basis of multidrug transport by ABC transporters. Biochim Biophys Acta1794: 725–737.

Sharom FJ (2008). ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics9: 105–127.

Szakacs G, Varadi A, Ozvegy-Laczka C, Sarkadi B (2008). The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox). Drug Discov Today13: 379–393.

Wanders RJ, Visser WF, van Roermund CW, Kemp S, Waterham HR (2007). The peroxisomal ABC transporter family. Pflugers Arch453: 719–734.

References

  1. Bakos E, Homolya L. Pflugers Arch. 2007;453:621–641. doi: 10.1007/s00424-006-0160-8. [DOI] [PubMed] [Google Scholar]
  2. Elliott AM, Al-Hajj MA. Mol Cancer Res. 2009;7:79–87. doi: 10.1158/1541-7786.MCR-08-0235. [DOI] [PubMed] [Google Scholar]
  3. Kamakura A, et al. Biochem Biophys Res Commun. 2008;377:847–851. doi: 10.1016/j.bbrc.2008.10.078. [DOI] [PubMed] [Google Scholar]
  4. Oguri T, et al. Mol Cancer Ther. 2007;6:122–127. doi: 10.1158/1535-7163.MCT-06-0529. [DOI] [PubMed] [Google Scholar]
  5. Oude Elferink RP, Paulusma CC. Pflugers Arch. 2007;453:601–610. doi: 10.1007/s00424-006-0062-9. [DOI] [PubMed] [Google Scholar]
  6. Pondarre C, et al. Blood. 2007;109:3567–3569. doi: 10.1182/blood-2006-04-015768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Reid G, et al. Proc Natl Acad Sci USA. 2003;100:9244–9249. doi: 10.1073/pnas.1033060100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Stieger B. Curr Opin Lipidol. 2009;20:176–181. doi: 10.1097/MOL.0b013e32832b677c. [DOI] [PubMed] [Google Scholar]
  9. Zuo Y, et al. J Biol Chem. 2008;283:36624–36635. doi: 10.1074/jbc.M807377200. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES